Education
About Us
Working with TipRanks
Follow Us
Zhongzhi Pharmaceutical Holdings Limited (HK:3737)
:3737
Total Valuation
Zhongzhi Pharmaceutical Holdings Limited has a market cap or net worth of HK$575.96M. The enterprise value is HK$868.30M.
Market CapHK$575.96M
Enterprise ValueHK$868.30M
Share Statistics
Zhongzhi Pharmaceutical Holdings Limited has 863,600,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding863,600,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Zhongzhi Pharmaceutical Holdings Limited’s return on equity (ROE) is 0.09 and return on invested capital (ROIC) is 6.35%.
Return on Equity (ROE)0.09
Return on Assets (ROA)0.05
Return on Invested Capital (ROIC)6.35%
Return on Capital Employed (ROCE)0.10
Revenue Per Employee859.44K
Profits Per Employee57.00K
Employee Count2,577
Asset Turnover1.11
Inventory Turnover2.68
Valuation Ratios
The current PE Ratio of Zhongzhi Pharmaceutical Holdings Limited is 25.9. Zhongzhi Pharmaceutical Holdings Limited’s PEG ratio is -0.20.
PE Ratio25.9
PS Ratio0.35
PB Ratio0.70
Price to Fair Value0.70
Price to FCF19.84
Price to Operating Cash Flow2.73
PEG Ratio-0.20
Income Statement
In the last 12 months, Zhongzhi Pharmaceutical Holdings Limited had revenue of 2.21B and earned 95.21M in profits. Earnings per share was 0.11.
Revenue2.21B
Gross Profit1.29B
Operating Income129.84M
Pretax Income146.90M
Net Income95.21M
EBITDA170.39M
Earnings Per Share (EPS)0.11
Cash Flow
In the last 12 months, operating cash flow was 197.40M and capital expenditures -63.79M, giving a free cash flow of 133.61M billion.
Operating Cash Flow197.40M
Free Cash Flow133.61M
Free Cash Flow per Share0.15
Dividends & Yields
Zhongzhi Pharmaceutical Holdings Limited pays an annual dividend of HK$0.05, resulting in a dividend yield of 7.35%
Dividend Per ShareHK$0.05
Dividend Yield7.35%
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.16
52-Week Price Change-29.17%
50-Day Moving Average0.76
200-Day Moving Average0.85
Relative Strength Index (RSI)39.83
Average Volume (3m)424.90K
Important Dates
Zhongzhi Pharmaceutical Holdings Limited upcoming earnings date is Mar 19, 2026, TBA (Confirmed).
Last Earnings DateAug 26, 2025
Next Earnings DateMar 19, 2026
Ex-Dividend DateMay 23, 2025
Financial Position
Zhongzhi Pharmaceutical Holdings Limited as a current ratio of 1.39, with Debt / Equity ratio of 12.85%
Current Ratio1.39
Quick Ratio0.91
Debt to Market Cap0.11
Net Debt to EBITDA0.13
Interest Coverage Ratio18.57
Taxes
In the past 12 months, Zhongzhi Pharmaceutical Holdings Limited has paid 50.75M in taxes.
Income Tax50.75M
Effective Tax Rate0.35
Enterprise Valuation
Zhongzhi Pharmaceutical Holdings Limited EV to EBITDA ratio is 4.74, with an EV/FCF ratio of 20.38.
EV to Sales0.36
EV to EBITDA4.74
EV to Free Cash Flow20.38
EV to Operating Cash Flow4.45
Balance Sheet
Zhongzhi Pharmaceutical Holdings Limited has HK$176.31M in cash and marketable securities with HK$139.50M in debt, giving a net cash position of HK$36.81M billion.
Cash & Marketable SecuritiesHK$176.31M
Total DebtHK$139.50M
Net CashHK$36.81M
Net Cash Per ShareHK$0.04
Tangible Book Value Per ShareHK$1.31
Margins
Gross margin is 57.00%, with operating margin of 5.86%, and net profit margin of 4.30%.
Gross Margin57.00%
Operating Margin5.86%
Pretax Margin6.63%
Net Profit Margin4.30%
EBITDA Margin7.69%
EBIT Margin5.39%
Analyst Forecast
The average price target for Zhongzhi Pharmaceutical Holdings Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-1.99%
EPS Growth Forecast-81.52%